Real-world effectiveness and safety of pembrolizumab in mismatch repair-deficient (dMMR) gastrointestinal non-colorectal tumors.

  1. Martinez Lago, Nieves 4
  2. Gonzalez Villarroel, Paula 7
  3. Cousillas Castiñeira, Antia 5
  4. Grana Suarez, Begona 3
  5. Gallardo Martin, Elena 7
  6. Agraso Busto, Sara 4
  7. Carral Maseda, Alberto 1
  8. Fernandez Montes, Ana 6
  9. Vazquez, Maria Francisca 2
  10. Reboredo Lopez, Margarita 3
  11. Galician Research Group on Digestive Tumors (GiTUD)
  1. 1 Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain
  2. 2 Complexo Hospitalario Universitario de Santiago de Compostela, Santiago De Compostela, Spain
  3. 3 University Hospital A Coruña, A Coruña, Spain
  4. 4 Complexo Hospitalario Universitario de Ferrol, Ferrol, Spain
  5. 5 Medical Oncology Department-Complejo Hospitalario de Pontevedra, Pontevedra, Spain
  6. 6 Department of Medical Oncology Complejo Hospitalario Universitario de Ourense, Ourense, Spain
  7. 7 Alvaro Cunqueiro Hospital, Vigo, Spain
Show affiliations +
Journal:
Journal of Clinical Oncology

ISSN: 0732-183X,  1527-7755

Year of publication: 2024

Volume: 42

Issue: 3_suppl

Pages: 733-733

Type: Article

DOI: 10.1200/JCO.2024.42.3_SUPPL.733 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Journal of Clinical Oncology

€ View funding

Funding information

Funders

  • None.